Subcutaneous daratumumab offers shorter clinic visits and high tolerability for patients with multiple myeloma, says ...

Ronald Bleday, MD, explained that a model to reduce opioid use in patients after colorectal surgery relies on nurses familiar ...

Cancer survivors, particularly men, in physically demanding jobs often face pressure to keep working during treatment, says ...

Explore essential mental health support strategies for older adults with cancer, addressing grief, community resources, and ...

Nurses should be familiar with PET scan protocol and what to ask patients with lung and bone cancers before administering ...

For patients with HR-positive breast cancer, adverse effects vary by CDK4/6 inhibitor, says Courtney Moore, APRN, FNP-C, OCN.

Panelists discuss that shifting talquetamab dosing from weekly to every 2 weeks improves response durability and patient ...

Panelists discuss how the unprecedented 5-year progression-free survival benefit (60% vs 8%) demonstrated in the CROWN trial ...

Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T-cell engagers, ...

C, CNS, explained that understanding a patient’s emotional needs can help educate them on treatment adherence.

Hope S. Rugo, MD, FASCO, outlined the top considerations for nurses managing toxicities related to PI3K and AKT inhibitors in ...

Panelists discuss how dose modifications for ALK inhibitors can significantly improve quality-of-life issues such as brain ...